Director option grant gives Quantum Cyber (QUCY) 191,860-share award

Q: What are the vesting terms of Peter O'Rourke’s Quantum Cyber (QUCY) stock options?

The stock options vest in eighteen substantially equal installments on each monthly anniversary of the grant date. Vesting is conditioned on O'Rourke continuing to provide services to Quantum Cyber through each applicable vesting date, aligning the award with ongoing service.

Q: What exercise price and expiration apply to the Quantum Cyber (QUCY) options granted to O'Rourke?

The options have an exercise price of 1.1400 per share and an expiration date of August 3, 2036 . They are Stock Options (Right to Buy) for Ordinary Shares, giving O'Rourke the right to purchase shares at that fixed price before expiration.

Q: What corrections does this Quantum Cyber (QUCY) Form 4/A amendment make?

The amendment corrects four items : the date of the reported transaction, the quantity of securities acquired, the number of shares underlying the acquired securities, and the quantity of securities beneficially owned by Peter O'Rourke following the transaction, providing updated ownership information.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

O'Rourke Peter reported acquisition or exercise transactions in this Form 4 filing.

Quantum Cyber N.V. director Peter O'Rourke received a grant of 191,860 stock options on July 22, 2026, each exercisable at 1.1400 per share for Ordinary Shares and expiring August 3, 2036. The amended report corrects the transaction date, option and underlying share quantities, and post-transaction beneficial ownership, and now shows 191,860 derivative securities held directly. The options vest in eighteen substantially equal installments on each monthly anniversary of the grant date, contingent on O'Rourke continuing to provide services.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Rourke Peter

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) ^{F1, F2}	191,860	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 191,860 shares (Direct)

Footnotes (2)

F1. The purpose of this Form 4/A is to correct (i) the date of the reported transaction, (ii) the quantity of securities acquired by the Reporting Person, (iii) the number of shares underlying the securities acquired by the Reporting Person, and (iv) the quantity of securities beneficially owned by the Reporting Person following the reported transaction.
F2. The Stock Options will vest in eighteen substantially equal installments on each monthly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates.

Key Figures

Stock options granted: 191860.0000 Exercise price: 1.1400 per share Expiration date: 2036-08-03 +2 more

5 metrics

Stock options granted 191860.0000 Stock Option (Right to Buy) granted to director on July 22, 2026

Exercise price 1.1400 per share Conversion or exercise price of the granted stock options

Expiration date 2036-08-03 Expiration of the Stock Option (Right to Buy)

Derivative securities owned after grant 191860.0000 Total stock options beneficially owned following the reported transaction

Vesting installments 18 Options vest in eighteen substantially equal monthly installments

Key Terms

Stock Option (Right to Buy), Ordinary Shares, beneficially owned

3 terms

Stock Option (Right to Buy) financial

"Security title "Stock Option (Right to Buy)" reported for the grant"

Ordinary Shares financial

"Underlying security title listed as "Ordinary Shares" for the options"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

beneficially owned financial

"quantity of securities beneficially owned by the Reporting Person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 07:53 PM Accepted by SEC EDGAR 08/06/2026 - 07:53 PM

FAQ

What insider transaction did Quantum Cyber (QUCY) report in this Form 4/A?

Quantum Cyber reported that director Peter O'Rourke received 191,860 stock options, each exercisable at 1.1400 per share for Ordinary Shares and expiring on August 3, 2036. The grant was recorded at no purchase price and is held directly.

How many Quantum Cyber (QUCY) options does Peter O'Rourke hold after this amendment?

After the corrected grant, Peter O'Rourke beneficially owns 191,860 stock options directly. This figure reflects updated quantities of securities acquired and shares underlying the options, as well as corrected post-transaction beneficial ownership in the amended Form 4/A.

What are the vesting terms of Peter O'Rourke’s Quantum Cyber (QUCY) stock options?

The stock options vest in eighteen substantially equal installments on each monthly anniversary of the grant date. Vesting is conditioned on O'Rourke continuing to provide services to Quantum Cyber through each applicable vesting date, aligning the award with ongoing service.

What exercise price and expiration apply to the Quantum Cyber (QUCY) options granted to O'Rourke?

The options have an exercise price of 1.1400 per share and an expiration date of August 3, 2036. They are Stock Options (Right to Buy) for Ordinary Shares, giving O'Rourke the right to purchase shares at that fixed price before expiration.

What corrections does this Quantum Cyber (QUCY) Form 4/A amendment make?

The amendment corrects four items: the date of the reported transaction, the quantity of securities acquired, the number of shares underlying the acquired securities, and the quantity of securities beneficially owned by Peter O'Rourke following the transaction, providing updated ownership information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Rourke Peter

(Last)

(First)

(Middle)

SUITE 400, 200 CONNECTICUT AVE

(Street)

NORWALK

CONNECTICUT

06854

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Quantum Cyber N.V. [ QUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/04/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$1.14	07/22/2026⁽¹⁾		A		191,860⁽¹⁾		⁽²⁾	08/03/2036	Ordinary Shares	191,860⁽¹⁾	$0	191,860⁽¹⁾	D

Explanation of Responses:

1. The purpose of this Form 4/A is to correct (i) the date of the reported transaction, (ii) the quantity of securities acquired by the Reporting Person, (iii) the number of shares underlying the securities acquired by the Reporting Person, and (iv) the quantity of securities beneficially owned by the Reporting Person following the reported transaction.

2. The Stock Options will vest in eighteen substantially equal installments on each monthly anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer through the applicable vesting dates.

	/s/ Peter O'Rourke	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR